JP2018527932A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018527932A5 JP2018527932A5 JP2018511706A JP2018511706A JP2018527932A5 JP 2018527932 A5 JP2018527932 A5 JP 2018527932A5 JP 2018511706 A JP2018511706 A JP 2018511706A JP 2018511706 A JP2018511706 A JP 2018511706A JP 2018527932 A5 JP2018527932 A5 JP 2018527932A5
- Authority
- JP
- Japan
- Prior art keywords
- treg cells
- human
- ifnγ
- cd45rc low
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021133065A JP7254128B2 (ja) | 2015-09-07 | 2021-08-18 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15306366.4 | 2015-09-07 | ||
| EP15306366 | 2015-09-07 | ||
| PCT/EP2016/070991 WO2017042170A1 (en) | 2015-09-07 | 2016-09-06 | A new subpopulation of cd8+cd45rclow tregs and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021133065A Division JP7254128B2 (ja) | 2015-09-07 | 2021-08-18 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018527932A JP2018527932A (ja) | 2018-09-27 |
| JP2018527932A5 true JP2018527932A5 (enExample) | 2019-09-26 |
Family
ID=54196910
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018511706A Pending JP2018527932A (ja) | 2015-09-07 | 2016-09-06 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
| JP2021133065A Active JP7254128B2 (ja) | 2015-09-07 | 2021-08-18 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021133065A Active JP7254128B2 (ja) | 2015-09-07 | 2021-08-18 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20180251731A1 (enExample) |
| EP (1) | EP3347452B1 (enExample) |
| JP (2) | JP2018527932A (enExample) |
| KR (1) | KR102768442B1 (enExample) |
| CN (1) | CN108291203A (enExample) |
| AU (1) | AU2016318762B2 (enExample) |
| BR (1) | BR112018004454A2 (enExample) |
| CA (1) | CA2997646C (enExample) |
| ES (1) | ES2890818T3 (enExample) |
| IL (1) | IL257891B (enExample) |
| MX (1) | MX390494B (enExample) |
| WO (1) | WO2017042170A1 (enExample) |
| ZA (1) | ZA201801265B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018234827B2 (en) | 2017-03-15 | 2024-04-04 | Orca Biosystems Inc. | Compositions and methods for hematopoietic stem cell transplants |
| WO2019012024A1 (en) | 2017-07-13 | 2019-01-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | METHODS FOR INCREASING EXPANSION AND IMMUNOSUPPRESSIVE CAPACITY OF A CD8 + CD45RCBAS TREGS POPULATION / - |
| KR102795692B1 (ko) | 2018-01-19 | 2025-04-16 | 밀테니 비오텍 비.브이. & 씨오. 케이지 | 키메라 항원 수용체를 발현하는 조절 t 세포 |
| EP3749334B1 (en) | 2018-02-08 | 2024-12-11 | The Board of Trustees of the Leland Stanford Junior University | Allogenic hematopoietic stem cell transplantation |
| EP3765121A4 (en) * | 2018-03-14 | 2021-12-22 | Thermogenesis Corp. | ACTIVATION / TRANSDUCTION SYSTEMS AND METHODS COMPATIBLE WITH CELL SORTING ACTIVATED BY BUOYANCY |
| US20230043255A1 (en) | 2018-11-14 | 2023-02-09 | Flagship Pioneering Innovations V, Inc. | Fusosome compositions for t cell delivery |
| WO2020120786A1 (en) | 2018-12-14 | 2020-06-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Isolated mhc-derived human peptides and uses thereof for stimulating and activating the suppressive function of cd8+cd45rclow tregs |
| BR112021021528A2 (pt) * | 2019-04-30 | 2022-04-19 | Univ California | Expansão ex vivo livre de contas de células t reguladoras humanas |
| EP4013780A4 (en) * | 2019-08-14 | 2024-04-10 | The Regents Of The University Of California | CAR T CELLS SPECIFIC FOR MODIFIED PROTEINS IN EXTRACELLULAR SPACES |
| WO2024028486A1 (en) * | 2022-08-04 | 2024-02-08 | Nantes Universite | In vitro method for obtaining clinical-grade cd8+ cd45rclow/- regulatory t cells |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE460475T1 (de) * | 2000-04-11 | 2010-03-15 | Univ Southern California | Methode zur verhinderung der transplantatabstossung unter verwendung von tgf- beta zur induktion von t-suppressorzellen |
| US20100135974A1 (en) * | 2007-01-31 | 2010-06-03 | Yeda Research And Development Co. Ltd. | Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease |
| WO2015150492A2 (en) * | 2014-04-01 | 2015-10-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An isolated donor mhc-derived peptide and uses thereof |
| EP3169350B1 (en) * | 2014-07-17 | 2019-01-09 | INSERM - Institut National de la Santé et de la Recherche Médicale | An isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases |
-
2016
- 2016-09-06 AU AU2016318762A patent/AU2016318762B2/en active Active
- 2016-09-06 MX MX2018002849A patent/MX390494B/es unknown
- 2016-09-06 EP EP16769882.8A patent/EP3347452B1/en active Active
- 2016-09-06 KR KR1020187009677A patent/KR102768442B1/ko active Active
- 2016-09-06 CN CN201680064881.0A patent/CN108291203A/zh active Pending
- 2016-09-06 WO PCT/EP2016/070991 patent/WO2017042170A1/en not_active Ceased
- 2016-09-06 BR BR112018004454A patent/BR112018004454A2/pt not_active Application Discontinuation
- 2016-09-06 ES ES16769882T patent/ES2890818T3/es active Active
- 2016-09-06 US US15/758,139 patent/US20180251731A1/en not_active Abandoned
- 2016-09-06 JP JP2018511706A patent/JP2018527932A/ja active Pending
- 2016-09-06 CA CA2997646A patent/CA2997646C/en active Active
-
2018
- 2018-02-23 ZA ZA2018/01265A patent/ZA201801265B/en unknown
- 2018-03-05 IL IL257891A patent/IL257891B/en active IP Right Grant
-
2021
- 2021-08-18 JP JP2021133065A patent/JP7254128B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018527932A5 (enExample) | ||
| Sullivan et al. | Treg-cell-derived IL-35-coated extracellular vesicles promote infectious tolerance | |
| Beres et al. | The role of regulatory T cells in the biology of graft versus host disease | |
| Lim et al. | Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell–driven B cell responses | |
| Xiao et al. | Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2rγnull mice | |
| Kelsen et al. | FoxP3+ CD4+ CD25+ T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease | |
| Björkström et al. | Tissue‐specific effector functions of innate lymphoid cells | |
| CN108463547A (zh) | 通过改变细胞表面信号和信号比选择性扩增不同的t细胞亚群 | |
| Roberts et al. | TNF blockade maintains an IL-10+ phenotype in human effector CD4+ and CD8+ T cells | |
| CN102459577B (zh) | 适合临床应用于免疫介导性疾病的、具有增强型抑制功能的调节性t细胞的体外扩增方法 | |
| Tawara et al. | Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease | |
| Davies et al. | Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release | |
| Pereira et al. | Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations | |
| Ebner et al. | Pathogen-reactive T helper cell analysis in the pig | |
| Radhakrishnan et al. | BCG vaccination reduces the mortality of Mycobacterium tuberculosis–infected type 2 diabetes mellitus mice | |
| Volchenkov et al. | In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome | |
| Zhu et al. | Granzyme B producing B-cells in renal transplant patients | |
| Domingues et al. | Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus | |
| Teshima et al. | Regulatory T cells and IL-17-producing cells in graft-versus-host disease | |
| Mangus et al. | Rapamycin resistant murine th9 cells have a stable in vivo phenotype and inhibit graft-versus-host reactivity | |
| Lin et al. | Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4+ CD25+ T cells | |
| CN107206258A (zh) | 衣原体激活的b细胞平台及其方法 | |
| Jin et al. | Enhanced suppression of the xenogeneic T-cell response in vitro by xenoantigen stimulated and expanded regulatory T cells | |
| Jin et al. | Large-scale in vitro expansion of human regulatory T cells with potent xenoantigen-specific suppression | |
| Daniele et al. | Treg cells: Collection, processing, storage and clinical use |